Vaxcyte (5VA) Q3 2024 Earnings Report
DE:5VA Q3 2024 EPS Results
- Actual EPS
- -EUR 0.74
- Consensus EPS
- -EUR 0.98
- Beat/Miss
- Beat by +EUR 0.24
- One Year Ago EPS
- -EUR 0.81
DE:5VA Q3 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/05/2024
- Time
- After Close
- Conference Call
- Tuesday, November 5, 2024
DE:5VA Upcoming Earnings
Vaxcyte's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:5VA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2026 (Q3) | -1.89- | -1.39 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -1.84-1.76 | -1.09 | -61.48% (-0.67) | |
| May 06, 2026 | 2026 (Q1) | -1.59-2.06 | -0.93 | -121.15% (-1.13) | |
| Feb 24, 2026 | 2025 (Q4) | -1.37-1.62 | -0.91 | -77.45% (-0.71) | |
| Nov 04, 2025 | 2025 (Q3) | -1.11-1.39 | -0.74 | -87.95% (-0.65) | |
| Aug 06, 2025 | 2025 (Q2) | -1.04-1.09 | -0.98 | -10.91% (-0.11) | |
| May 07, 2025 | 2025 (Q1) | -0.95-0.93 | -0.76 | -22.35% (-0.17) | |
| Feb 25, 2025 | 2024 (Q4) | -0.99-0.91 | -1.64 | 44.26% (+0.72) | |
| Nov 05, 2024 | 2024 (Q3) | -0.98-0.74 | -0.81 | 8.79% (+0.07) | |
| Aug 06, 2024 | 2024 (Q2) | -0.87-0.98 | -0.63 | -57.14% (-0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
